Loading clinical trials...

Improving Blood Pressure Control Through the myBPmyLife mHealth Application | Clinical Trials | Clareo Health

COMPLETEDNA

Improving Blood Pressure Control Through the myBPmyLife mHealth Application

Improving Blood Pressure Control Through the myBPmyLife mHealth Application: A Wearables in Reducing Risk and Enhancing Daily Lifestyle (WIRED-L) Center Study

NCT05154929•University of Michigan

View on ClinicalTrials.gov

Summary

This study is enrolling eligible participants that have high blood pressure. Reducing dietary salt intake and engaging in regular physical activity is known to decrease blood pressure in people with hypertension. This trial will determine whether a smartwatch and a mobile health application, which together deliver notifications, can increase activity levels and reduce salt intake for people with high blood pressure. All study activities will be completed online or via a mobile medical application. Participants will not have any face-to-face visits with the study team.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Self-reported history of hypertension and no hypertensive medication changes in the last 4 weeks.
•A smartphone with a compatible Apple or Android operating system installed and able to download and use the myBPmyLife app including accepting all permissions
•A valid email address
•Fluent in spoken and written English
•Signed written informed consent. (Note that each participant must be able to consent for themselves.)

Exclusion Criteria

•Contraindication to performing physical activity or following a sodium restriction diet. The participant must be able to walk and eat on their own without assistive devices.
•Unstable symptoms or markedly elevated BP at enrollment (defined as systolic BP\>180 mmHg, diastolic BP\>120 millimeters of mercury (mmHg))
•Known secondary causes of hypertension (e.g., adrenal insufficiency, pheochromocytoma), heart failure, or end-stage renal disease
•Difficulty using an upper arm blood pressure cuff due to biceps size or end-stage renal disease or difficulty comfortably wearing a smartwatch
•Wrist too large to wear a smartwatch comfortably.
•Daily sodium intake less than 1500 mg/day as measured by the sodium screener
•Currently pregnant or planning to become pregnant in the next six months

Locations (2)

University of Michigan

Ann Arbor, Michigan, United States

Hamilton Community Health Network

Flint, Michigan, United States

Key Dates

Start Date

December 21, 2021

Primary Completion Date

January 27, 2024

Completion Date

January 27, 2024

Last Updated

February 20, 2024

Enrollment

608

ACTUAL participants

Conditions

Hypertension

Interventions

Dietary and physical activity JITAI delivered through the myBPmyLife app

BEHAVIORAL

Control Group

OTHER

Natural History of Noncirrhotic Portal Hypertension

NCT02417740

Cystic FibrosisImmunologic Deficiency Syndrome+3 more

View study

RECRUITING

Homocysteine and Early Diastolic Dysfunction in Newly Diagnosed Hypertension

NCT07480265

Hypertension (HTN)Hyperhomocysteinemia+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 20, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Improving Blood Pressure Control Through the myBPmyLife mHealth Application

Inclusion Criteria

Exclusion Criteria

Natural History of Noncirrhotic Portal Hypertension

Homocysteine and Early Diastolic Dysfunction in Newly Diagnosed Hypertension

A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489

Mobile Cued Adherence Therapy (mCAT) for Blood Pressure Medication

Penn Medicine Healthy Heart

Preliminary Human Trials of F230 Tablets